IL-6 is a cytokine with a number of biological functions, including stimulation of immunoglobulin synthesis and proliferation of early hematopoietic stem cells. We showed that lymphotoxin stimulated accumulation of IL-6 mRNA in human fibroblasts (W138) in a dose-responsive fashion; tumor necrosis factor-alpha (TNF-a) was about threefold more potent than lymphotoxin. Further experiments suggested that stimulation by lymphotoxin was independent of protein kinase C activity, did not require new protein synthesis, and was at least in part a result of increased stabilization of IL-6 mRNA. t1/2 of the IL-6 transcripts increased from 03 h in unstimulated cells to 0.85 h in cells stimulated with lymphotoxin. In addition, stimulators of protein kinase C, including phorbol esters and teleocidin, enhanced accumulation of IL-6 mRNA. Cycloheximide (CHX), inhibitor of protein synthesis, also markedly increased levels of IL-6 mRNA. Both CHX and activators of protein kinase C increased by > 16-fold the stability of IL-6 mRNA. Further, dose-response studies showed that sodium fluoride (NaF), activator of G-binding proteins, and ouabain, inhibitor of Na+/H+ pump, increased levels of IL-6 mRNA. NaF stimulated IL-6 mRNA levels independent of protein kinase C activity. These results suggest that stimulators of several pathways of signal transduction increase levels of IL-6 mRNA and posttranscriptional stabilization is, in part, the mechanism that many of these signals, including lymphotoxin, use to increase levels of IL-6 RNA. (J. Clin. Invest. 1990. 85:121-129.) messenger RNA -posttranscriptional stabilization
Introduction IL-6 is a 2 l-kD glycoprotein containing 184 amino acid residues derived from a precursor peptide of 212 amino acids. The amino-terminal of IL-6 shares homology with granulocytecolony stimulating factor (G-CSF)' (1) . IL-6 contains five exons (2) and is located on chromosome 7 (3). This cytokine was previously known as IFN-#f-2, 26K protein, B-cell stimulating factor-2, hybridoma growth factor, or hepatocyte-stimulating factor (4) . IL-6 appears to have a variety of functions, Address reprint requests to Dr. M. Akashi, UCLA Division of Hematology/Oncology, 11-240 Factor Building, Los Angeles, CA 90024-
1678.
Receivedforpublication 27 March 1989 and in revisedform 24 July 1989. including stimulation of proliferation of early hematopoietic stem cells and megakaryocytes, induction of differentiation of B lymphocytes, and stimulation of the liver to produce acute phase-reactive proteins.
Tumor necrosis factor-alpha (TNF-a), also known as TNF, is produced predominately by myeloid cells, especially macrophages (5, 6) . Lymphotoxin, also known as TNF-,6, is synthesized predominately by activated lymphocytes (5, 7, 8) . Lymphotoxin has structural similarities to TNF and both are cytolytic or cytostatic for transformed cells (9, 10) . Previously, Kohase et al. (11) reported that TNF-a and several other agents, including a phorbol ester, stimulated normal fibroblasts to synthesize IL-6, and their data suggested that the stimulation was probably mediated through activation of the protein kinase C pathway (12) . However, little is known ofthe role that lymphotoxin plays in modulation of IL-6 expression. In this study, we show that stimulators of several pathways of signal transduction elevate levels of IL-6 mRNA and stabilization of these transcripts is, in part, the mechanism that many of these signals, including lymphotoxin, use to increase levels of IL-6 mRNA.
Methods
Reagents. Recombinant human TNF-a (5.6 X 107 U/mg protein) and recombinant lymphotoxin (2 X 108 U/mg protein) were generously supplied by M. Shephard, Genentech Inc. (South San Francisco, CA); both were expressed in Escherichia coli. Both contained low levels of endotoxin (TNF-a preparation, < 0.03 EU/mg protein; lymphotoxin preparation, 3.13 EU/mg protein). Specific activity of each was assayed twice; once at Genentech and then at UCLA by examining their cytolytic activity on actinomycin-D-treated L929 fibroblasts (6) . Results were nearly identical. 1 2-0-tetradecanoylphorbol 13-acetate (TPA), 4-0-methyl TPA, phorbol 12,13-didecanoate (PDD), 4a-PDD, and phorbol 12,13-dibutyrate (PDB) were purchased from Sigma Chemical Co. (St. Louis, MO), dissolved in acetone, and stored at -20'C until use. All other reagents were also ofthe best grade available from Sigma Chemical Co.
Cells and cell culture. Normal human embryonic lung fibroblast (W138, obtained from the American Type Tissue Culture Collection) and a human lung adenocarcinoma cell line (Lu-CSF-l) (13) were cultured in a medium (Flow Laboratories, Inc., McLean, VA) supplemented with 10% FCS in a humidified atmosphere containing 5% CO2. Cells were harvested by treatment with 0.05% trypsin, 0.02% EDTA (wt/vol) in PBS. Conditioned media (CM) from confluent cultures containing WI38 fibroblasts and either TNF-a or lymphotoxin were prepared by centrifuging the supernatants at 1,000 g for 10 min, putting them through filters (0.22 Mm; Millipore Corp., Bedford, MA), and storing at -20'C until use.
Measurement ofIL-6 bioactivity. IL-6 levels were measured using the IL-6-dependent murine hybridoma clone, MH60.BSF2, in a bioassay (14) . These hybridoma cells are absolutely dependent on IL-6;   IL-la and fl, IL-2, IL-3, IIA, IL-5, IFN-a or -y, and G-CSF do not induce their growth (12 Protein kinase C assay. The activity of protein kinase C was assayed as described previously (19) . Briefly, soluble (cytosol) and solubilized particulate (membrane) fractions ofcells were prepared, and both fractions were assayed for protein kinase C activity using histone H I as substrate. The amounts ofprotein kinase C in the cytosolic (22 
Results
Lymphotoxin induction of IL-6 protein in fibroblasts. Lymphotoxin was added to subconfluent cultures of W138 lung fibroblasts for 4 d; CM were harvested for IL-6 activity ( Fig. 1) . In the absence of lymphotoxin, fibroblasts constitutively produced IL-6 protein. Lymphotoxin enhanced production of IL-6 in a dose-dependent manner. 104 U/ml lymphotoxin stimulated approximately five times greater concentration of IL-6 than was constitutively produced. The activity of IL-6 in the CM cells cultured with 103 U/ml lymphotoxin was almost neutralized by antibody (78±1%). Additional control experiments showed that fresh culture media containing 103 or 104 U/ml lymphotoxin inhibited [3H]Tdr incorporation in the IL-6 responder cells (MH60.BSF2) by < 5% of untreated control cultures (data not shown). (20) .
Treatment of cells with 5 or 50 jg/ml teleocidin for 2 h increased accumulation of IL-6 mRNA about fourfold compared with untreated cells (Fig. 3 A) . TPA, PDD, and PDB are phorbol esters that are potent activators of protein kinase C; their derivatives, 4-0-methyl TPA and 4-a-PDD are unable to activate protein kinase C (21). Fibroblasts were exposed to each compound (50 nM) for 2 h and levels of IL-6 mRNA measured. Potency of the phorbol ester to stimulate accumulation of IL-6 mRNA in fibroblasts paralleled their known abilities to activate protein kinase C (Fig. 3 B) .
Effect of inactivation ofprotein kinase C on expression of IL-6 mRNA stimulated by either NaF or lymphotoxin. NaF is an activator of several G-binding proteins (22) . To determine whether NaF stimulates IL-6 mRNA accumulation, fibroblasts were cultured with NaF at different concentrations for 4 h. 5mM NaF stimulated a 28-fold increased accumulation of IL-6 mRNA as compared with untreated control cells (Fig.  4 A) . Cells exposed for prolonged durations to TPA reduce their protein kinase C activity, thus making them resistant to repeated exposure to TPA (23). We showed that treatment with 100 nM TPA for 24 h decreased protein kinase C activity by > 80% and decreased cell membrane-binding of [3H]PDB by > 90%, and reexposure to TPA did not stimulate the activity of protein kinase C (data not shown). Fibroblasts incubated with TPA (50 nM) for 4 h contained markedly increased levels of IL-6 mRNA compared with untreated cells (Fig. 4 B) . Pro- longed exposure (24 h) of cells to TPA did not stimulate their accumulation of IL-6 mRNA; reexposure ofthese cells to TPA for 4 h had 60% lower levels of IL-6 mRNA as compared with those cells cultured with TPA for 4 h alone. In contrast, the enhanced levels of IL-6 mRNA mediated by NaF or lymphotoxin were not blocked by preexposure of the cells to TPA for 24 h (Fig. 4 B) . The combination of 24-h exposure to TPA plus an additional 4 h of TPA and NaF stimulated the accumulation of IL-6 mRNA slightly more than NaF alone. The reason for this enhanced stimulation is not clear. These experiments were repeated three times with similar results (data not shown).
Effect ofouabain on expression ofIL-6 mRNA. Fibroblasts were cultured with ouabain (inhibitor of Na+/H+ pump; 24); cytoplasmic RNA was extracted and analyzed for IL-6 mRNA levels. Exposure to ouabain markedly increased accumulation of IL-6 mRNA in a dose-dependent manner (Fig. 5) . Time-response experiments showed that within 4 h, ouabain increased IL-6 mRNA levels by 20-fold, and a 100-fold increase occuffed at 24 h (data not shown).
Effect of lymphotoxin on expression ofIL-6 mRNA in the absence ofprotein synthesis infibroblasts. Fibroblasts cultured with 20 sg/ml CHX (inhibitor of protein synthesis) decreased protein synthesis by 93% as compared with untreated cells.
Cells cultured initially with CHX (20.0 ,g/ml) and followed by the addition of lymphotoxin had a 98-fold enhanced accumulation of IL-6 mRNA as compared with untreated control cells (Fig. 6 ). This enhancement was greater than those observed when the cells were cultured with either lymphotoxin (fivefold) or CHX (59-fold) alone.
Stability ofsteady-state IL-6 mRNA infibroblasts exposed to either lymphotoxin, TNF, TPA, or CHX. To examine for posttranscriptional regulation of expression of IL-6 mRNA, untreated fibroblasts or those exposed to lymphotoxin (4,000 U/ml), TNF-a (1,000 U/ml), TPA (50 nM), or CHX (5 Ag/ml) for 4 h were also cultured with actinomycin D for an additional 0.5-4.0 h. Samples were sequentially harvested and examined for levels of IL-6 mRNA. t1/2 of steady state IL-6 mRNA in unstimulated fibroblasts was 0.3 h (Fig. 7) . tI/2 of IL-6 mRNA was 0.85 h after culture with either lymphotoxin or TNF-a (Fig. 7) and was > 4 h after exposure to either TPA or CHX (Fig. 8) . Similar results were observed in three more experiments.
Discussion
We have examined levels of IL-6 mRNA in fibroblasts after their exposure to either lymphotoxin or stimulators of several signal pathways. Lymphotoxin is a glycoprotein produced by activated lymphocytes (7, 8, (25) (26) (27) ; it can inhibit the growth of a variety of cells transformed by chemicals or viruses (28, 29) . Many of the actions of lymphotoxin are similar or identical to those observed with TNF-a. Lymphotoxin and TNF-a probably share the same cell surface receptors (30) . Previously, we have observed that lymphotoxin stimulates normal fibroblasts to produce several hematopoietic CSFs (31) . In this study, we have found that normal lung fibroblasts constitutively produced IL-6 mRNA. After exposure to lymphotoxin, levels of IL-6 mRNA increased in these cells more than fourfold. TNF-a was about three times more potent than lymphotoxin at equivalent concentrations of these cytokines.
Protein kinase C is involved in signal transduction by coupling receptor-mediated inositol phospholipid turnover with a variety of cellular functions (32). We have observed that both phorbol diesters and nonphorbol compounds that activate protein kinase C stimulated accumulation of IL-6 mRNA in the fibroblasts. In contrast, phorbol esters incapable of activating protein kinase C were unable to stimulate increased concentrations of IL-6 mRNA. In addition, we took advantage of the fact that prolonged exposure of cells to TPA leads to inactivation of protein kinase C (33, 34) . Prolonged (24 h) exposure to TPA partially blocked accumulation of IL-6 mRNA after reexposure of cells to TPA. However under these same conditions, accumulation of IL-6 mRNA was not blocked after reexposure of the TPA-treated cells to lymphotoxin. mRNA levels by a protein kinase C-independent mechanism in human fibroblasts using similar methods (35) . Taken together, these results also suggest that lymphotoxin probably does not mediate accumulation of IL-6 mRNA through protein kinase C. Another study using putative inhibitors of protein kinase C suggested TNF-a stimulated accumulation of IL-6 mRNA through the protein kinase C pathway (12) . We also have found that the same inhibitors (H-7 and H-8, 50 mM for 2 h) could block the stimulation mediated by both TNF-a and lymphotoxin; but these agents also inhibited the stimulation mediated by NaF, CHX, and ouabain, and decreased total RNA synthesis by 70% (data not shown). In view of the very short 1/2 of IL-6 mRNA, we believe that the ability of H-7 to inhibit the accumulation of IL-6 mRNA mediated by lymphotoxin is probably a nonspecific effect.
A recent study suggested that G-binding proteins may be involved in transducing the signal mediated by TNF after binding to its receptors on leukemia cells (36) . In this regard, we have found that NaF stimulated the accumulation of IL-6 mRNA. F-ion in combination with Al3+ (usually present in trace amounts in tissue culture) binds and activates G-binding proteins. Preexposure of the fibroblasts to pertussis toxin (10-1,000 ng/ml for 4-24 h) was unable to block the action of (Fig. 7 A) or those exposed to lymphotoxin (4,000 U/ml, Fig. 7 B) ; TNF-a (1,000 U/ml, Fig NaF (data not shown). Several G-binding proteins are not ribosylated and therefore inactivated by pertussis toxin (37) .-NaF may modulate levels of IL-6 mRNA in fibroblasts through a G-binding protein pathway that is insensitive to pertussis toxin. In further experiments, our results suggest that the increase of levels of IL-6 mRNA mediated by NaF probably does not require protein kinase C because partial inactivation of this enzyme did not blunt the response of NaF.
We observed that ouabain markedly increased levels of IL-6 mRNA in a dose-dependent manner. Ouabain blocks the Na+/K+ pump, causing a rise of intracellular Na+ (24) . Increased intracellular Na+ levels can increase the cytoplasmic Cal' concentration. Prior studies showed that a Ca" ionophore can enhance levels of IL-6 mRNA (12) . Further studies are in progress to determine the importance of Na+ and/or Ca++ cellular fluxes in mediating the accumulation of IL-6 mRNA. The IL-6 mRNA level increased in the fibroblasts when new protein synthesis was nearly stopped by CHX. Seghal et al. also showed that exposure of human diploid fibroblasts to CHX increased their concentrations of IL-6 mRNA (9) . In addition, we have found that lymphotoxin was able to cause the accumulation of IL-6 mRNA in the absence ofnew protein synthesis.
To pursue further how lymphotoxin stimulated the increase in levels of IL-6 mRNA, we studied stability of IL-6 mRNA. In untreated fibroblasts, the t,/2 of IL-6 mRNA was 0.3 h. Exposure of the cells to either CHX or TPA markedly stabilized the message, with little decrease in levels at 4 h of exposure. IL-6 mRNA is a transiently expressed gene having an AU-rich 3' region, which may be a target for short-acting RNAses. Studies of Shaw and Kamen (38) suggested that TPA and CHX stabilized another cytokine (GM-CSF) by altering the response of the cell to this AU-rich region of the mRNA. TNF-a and lymphotoxin also consistently increased the stability of IL-6 mRNA, both increasing the t1/2 of IL-6 mRNA to -0.85 h as compared with the untreated, control fibroblasts. Further studies are now determining if the stabilization of mRNA by lymphotoxin requires the AU canonical sequences in the mRNA. We previously have found that TNF-a can increase levels of G-and GM-CSF mRNA by stabilization of these RNAs (13) (39) and the differentiation of B lymphocytes (40) . Lymphotoxin and IL-6 may also be involved in pathologic conditions. For example, affected joint spaces in rheumatoid arthritis often contain high levels of IL-6, lymphotoxin, TNF-a, and IL-1 (41) (42) (43) . These factors at least in part are capable of causing bone resorption, as well as collagen and cartilage destruction (42) (43) (44) (45) . Furthermore, the B and T lymphocytes, macrophages, and synovial cells within these joints may inappropriately develop a paracrine network through production ofthese cytokines, helping to maintain the chronic inflammatory rheumatoid joint. Fundamental understanding of cytokines and their interactions may lead to novel approaches to several diseases.
